Meet the Start-ups

Mike de Leeuw | CEO | OncoLize

The company was founded by Mike de Leeuw (CEO), who previously founded InGell Labs (2010), Branching Tree (2008) and DSM BioMedical (2005) and has a track record in re-structuring and re-financing other start-up’s within the controlled release/ biomedical materials space for drug delivery and cell therapy.

OncoLize

OncoLize (2017) is based in Maastricht, The Netherlands.

We develop high performance oncology products for localized and slow delivery of drugs, making our products:

Much better at eradicating the tumor
…with far less side-effects
… and triple A: Accessible and Affordable for All

Our injectable drug depots are simple to use, effective, safe and affordable.

We are currently preparing advanced formulations for First-in-Human trials using a selection of well-known Chemo-drugs. This is based on preliminary PDX-mice studies with human Lung- and Pancreatic tumor grafts. These aggressive tumors were halted in their growth and reversed towards eradication of the tumor mass… even without the support of an intact immune system, which human patients normally do have!